Categories: World

BRIEF-Shionogi Announces U.S. Availability Of Xocova® (Ensitrelvir), The First And Only Oral Option To Help Prevent Covid-19 Following Exposure*

July 28 (Reuters) – Shionogi & Co Ltd: * SHIONOGI ANNOUNCES U.S. AVAILABILITY OF XOCOVA® (ENSITRELVIR), THE FIRST AND ONLY ORAL OPTION TO HELP PREVENT COVID-19 FOLLOWING EXPOSURE*…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: July 28, 2026 18:22:10 IST

July 28 (Reuters) – Shionogi & Co Ltd: * SHIONOGI ANNOUNCES U.S. AVAILABILITY OF XOCOVA® (ENSITRELVIR), THE FIRST AND ONLY ORAL OPTION TO HELP PREVENT COVID-19 FOLLOWING EXPOSURE* Source text: Further

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: July 28, 2026 18:22:10 IST

Recent Posts

EBay, former executives to pay $56 million to settle couple's harassment case

By Nate Raymond July 28 (Reuters) - EBay and three former top executives have agreed…

July 28, 2026

EBay, former executives to pay $56 million to settle couple's harassment case

By Nate Raymond July 28 (Reuters) - EBay and three former top executives have agreed…

July 28, 2026

Parisians welcome 'legendary' Zidane as France team manager

VIDEO SHOWS: PARISIANS REACTING TO NAMING OF FORMER FRANCE MIDFIELDER AND REAL MADRID COACH, ZINEDINE…

July 28, 2026